Fecal Calprotectin Test Market revenue to hit USD 350 Million by 2035, says Research Nester
23 août 2023 07h30 HE
|
Research Nester
New York, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The global fecal calprotectin test market size is predicted to grow at a CAGR of over ~12% from 2023 to 2035. The market is projected to garner a revenue...
CVS Health to Begin Nationwide In-Store Sales of Biomerica’s EZ Detect™ Colorectal Disease Screening Test
03 août 2023 08h19 HE
|
Biomerica, Inc.
Over 7,000 CVS Pharmacy Stores to sell the EZ Detect™ TestSimple 2 minute at-home test detects an early warning sign of colorectal cancer IRVINE, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) --...
Global Radiation Oncology Market Expected to Reach $21.14 Billion by 2030: Technological Advancements and Global Cancer Burden Drive Growth
25 juil. 2023 07h08 HE
|
Research and Markets
Dublin, July 25, 2023 (GLOBE NEWSWIRE) -- The "Radiation Oncology Market Size, Share & Trends Analysis Report By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By...
Colorectal Cancer Screening Market Size to Surpass USD 23.03 billion by 2030, exhibiting a CAGR of 4.4%
19 juil. 2023 04h49 HE
|
Fortune Business Insights
Pune, India, July 19, 2023 (GLOBE NEWSWIRE) -- The global colorectal cancer screening market size was valued at USD 16.29 billion in 2022. The market is projected to grow from USD 17.05 billion in...
Fecal Immunochemical Diagnostic Test (FIT) Market to Surge with USD 2.1 Billion Expansion by 2031, According to TMR Study
06 juin 2023 08h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, June 06, 2023 (GLOBE NEWSWIRE) -- The market value of fecal immunochemical diagnostic tests (FITs) is expected to reach US$ 2.1 billion by 2031. Between 2023 and...
Global Radiation Oncology Market Report 2023: Demand for Advanced Cancer Treatment Options Fuels Growth
06 juin 2023 05h28 HE
|
Research and Markets
Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Global Radiation Oncology Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The global radiation...
Mainz Biomed Expands Commercial Footprint into Poland
31 mai 2023 03h01 HE
|
Mainz BioMed NV
Total addressable market in Poland is estimated at 21 million patients BERKELEY, Calif. and MAINZ, Germany, May 31, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the...
Mainz Biomed Processes First Patients from Colorectal Cancer Screening Campaign Through its Corporate Health Portal in Partnership with Zöeller-Kipper
24 mai 2023 03h01 HE
|
Mainz BioMed NV
Employees found the online patient portal, through which they ordered the ColoAlert® test, easy-to-use and convenient BERKELEY, Calif. and MAINZ, Germany, May 24, 2023 (GLOBE NEWSWIRE) --...
Mainz Biomed Announces First Quarter 2023 Financial Results and Provides Corporate Update
16 mai 2023 03h01 HE
|
Mainz BioMed NV
ColoAlert® Revenue Increases 152% Year Over Year BERKELEY, Calif. and MAINZ, Germany, May 16, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a...
Mainz Biomed Partners with Microba Life Sciences for the Development of PancAlert
10 mai 2023 03h01 HE
|
Mainz BioMed NV
Combination of DNA biomarkers with microbiome biomarkers has potential to enhance technical profile of novel pancreatic cancer screening test Joint research project to discover disease specific...